Israel Englander Chembio Diagnostics, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.35 - $1.1 $66,956 - $210,433	191,303 New	191,303 $69,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $31,087 - $57,936	-47,103 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $3,362 - $7,866	-3,085 Reduced 6.15%	47,103 $54,000
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $415,462 - $1.08 Million	-201,681 Reduced 80.07%	50,188 $125,000
Q2 2021 Aug 16, 2021	BUY	$2.88 - $5.64 $672,359 - $1.32 Million	233,458 Added 1268.04%	251,869 $748,000
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $62,597 - $146,735	18,411 New	18,411 $65,000
Q2 2019 Aug 14, 2019	SELL	$5.56 - $7.85 $72,774 - $102,748	-13,089 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.32 - $7.18 $69,633 - $93,979	13,089 New	13,089 $73,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.